Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor by periodontal fibroblasts

Journal of Periodontal Research

Volumn 47, Issue 2, 2012, Pages 165-173

  Agis, H ^a,b   Watzek, G ^a,b   Gruber, R ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Austrian Cluster for Tissue Regeneration   (Austria)

Author keywords

Fibroblast; Hypoxia inducible factor 1; Inflammation; Periodontal therapy; Prolyl hydroxylase inhibitors; Vascular endothelial growth factor

Indexed keywords

ANTIMUTAGENIC AGENT; AUTACOID; COBALT; COBALT CHLORIDE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DEFEROXAMINE; DICARBOXYLIC AMINO ACID; ENZYME INHIBITOR; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1; INTERLEUKIN 6; KI 67 ANTIGEN; MIMOSINE; MITOGEN ACTIVATED PROTEIN KINASE P38; OXALYLGLYCINE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN; PROTEIN KINASE INHIBITOR; SIDEROPHORE; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN A;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; GINGIVA; HUMAN; PERIODONTAL LIGAMENT;

AMINO ACIDS, DICARBOXYLIC; ANTIMUTAGENIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COBALT; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DEFEROXAMINE; ENZYME INHIBITORS; FIBROBLASTS; GINGIVA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KI-67 ANTIGEN; MIMOSINE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIODONTAL LIGAMENT; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEIN KINASE INHIBITORS; PROTEINS; SIDEROPHORES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857458226     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01415.x     Document Type: Article

References (38)

1. Cetinkaya BO, Keles GC, Ayas B, Sakallioglu EE, Acikgoz G. The expression of vascular endothelial growth factor in a rat model at destruction and healing stages of periodontal disease. J Periodontol 2007;78:1129-1135.
2. Cooke JW, Sarment DP, Whitesman LA et al. Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. Tissue Eng 2006;12:1441-1450.
3. Ihrcke NS, Parker W, Reissner KJ, Platt JL. Regulation of platelet heparanase during inflammation: role of pH and proteinases. J Cell Physiol 1998;175:255-267.
4. Ng KT, Li JP, Ng KM, Tipoe GL, Leung WK, Fung ML. Expression of hypoxia-inducible factor-1alpha in human periodontal tissue. J Periodontol 2011;82:136-141.
5. Johnson RB, Serio FG, Dai X. Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol 1999;70:848-852.
6. Thangarajah H, Yao D, Chang EI et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci USA 2009;106:13505-13510.
7. Albiero M, Menegazzo L, Boscaro E, Agostini C, Avogaro A, Fadini GP. Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice. Diabetologia 2011;54:945-953.
8. Galiano RD, Tepper OM, Pelo CR et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004;164:1935-1947.
9. Jazwa A, Kucharzewska P, Leja J et al. Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice. Genet Vaccines Ther 2010;8:6.
10. Fraisl P, Aragones J, Carmeliet P. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov 2009;8:139-152.
11. Shen X, Wan C, Ramaswamy G et al. Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice. J Orthop Res 2009;27:1298-1305.
12. Wan C, Gilbert SR, Wang Y et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci USA 2008;105:686-691.
13. Asikainen TM, White CW. HIF stabilizing agents: shotgun or scalpel? Am J Physiol Lung Cell Mol Physiol 2007;293:L555-L556.
14. Leger AJ, Altobelli A, Mosquea LM et al. Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine. J Bone Miner Metab 2010;28:510-519.
15. Asikainen TM, Ahmad A, Schneider BK et al. Stimulation of HIF-1alpha, HIF-2alpha, and VEGF by prolyl 4-hydroxylase inhibition in human lung endothelial and epithelial cells. Free Radic Biol Med 2005;38:1002-1013.
16. Kim KS, Rajagopal V, Gonsalves C, Johnson C, Kalra VK. A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J Immunol 2006;177:7211-7224.
17. Kotake-Nara E, Takizawa S, Quan J, Wang H, Saida K. Cobalt chloride induces neurite outgrowth in rat pheochromocytoma PC-12 cells through regulation of endothelin-2/vasoactive intestinal contractor. J Neurosci Res 2005;81:563-571.
18. Loboda A, Stachurska A, Florczyk U et al. HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells. Antioxid Redox Signal 2009;11:1501-1517.
19. Markel TA, Crisostomo PR, Wang M et al. Iron chelation acutely stimulates fetal human intestinal cell production of IL-6 and VEGF while decreasing HGF: the roles of p38, ERK, and JNK MAPK signaling. Am J Physiol Gastrointest Liver Physiol 2007;292:G958-G963.
20. Favier J, Plouin PF, Corvol P, Gasc JM. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am J Pathol 2002;161:1235-1246.
21. Hecht M, Papoutsi M, Tran HD, Wilting J, Schweigerer L. Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas. Cancer Res 2004;64:6109-6118.
22. Gruber R, Karreth F, Frommlet F, Fischer MB, Watzek G. Platelets are mitogenic for periosteum-derived cells. J Orthop Res 2003;21:941-948.
23. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;182:311-322.
24. Schultz K, Murthy V, Tatro JB, Beasley D. Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms. Am J Physiol Lung Cell Mol Physiol 2009;296:L921-L927.
25. Chaston TB, Lovejoy DB, Watts RN, Richardson DR. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311. Clin Cancer Res 2003;9:402-414.
26. Yoon G, Kim HJ, Yoon YS, Cho H, Lim IK, Lee JH. Iron chelation-induced senescence-like growth arrest in hepatocyte cell lines: association of transforming growth factor beta1 (TGF-beta1)-mediated p27Kip1 expression. Biochem J 2002;366:613-621.
27. Dong Z, Zhang JT. EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. Mol Biol Cell 2003;14:3942-3951.
28. Leger AJ, Altobelli A, Mosquea LM et al. Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine. J Bone Miner Metab 2010;28:510-519.
29. Wang Y, Wan C, Deng L et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007;117:1616-1626.
30. Veschini L, Belloni D, Foglieni C et al. Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib. Blood 2007;109:2565-2570.
31. Botusan IR, Sunkari VG, Savu O et al. Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci USA 2008;105:19426-19431.
32. Thornton RD, Lane P, Borghaei RC, Pease EA, Caro J, Mochan E. Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem J 2000;1:307-312.
33. Artese L, Piattelli A, de Gouveia Cardoso LA et al. Immunoexpression of angiogenesis, nitric oxide synthase, and proliferation markers in gingival samples of patients with aggressive and chronic periodontitis. J Periodontol 2010;81:718-726.
34. Ng KT, Li JP, Ng KM, Tipoe GL, Leung WK, Fung ML. Expression of hypoxia-inducible factor-1alpha in human periodontal tissue. J Periodontol 2011;82:136-141.
35. Huang S, Lu F, Zhang Z, Yang X, Chen Y. The role of psychological stress induced hypoxia-inducible factor-1alpha in rat experimental periodontitis. J Periodontol 2011;82:934-941.
36. Park HJ, Baek KH, Lee HL et al. Hypoxia inducible factor-1alpha directly induces the expression of receptor activator of nuclear factor-kappaB ligand in periodontal ligament fibroblasts. Mol Cells 2011;31:573-578.
37. Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, Dipietro LA. Regulation of scar formation by vascular endothelial growth factor. Lab Invest 2008;88:579-590.
38. Mack JA, Maytin EV. Persistent inflammation and angiogenesis during wound healing in K14-directed Hoxb13 transgenic mice. J Invest Dermato 2010;130:856-865.